Hong Ge

Kunming University of Science and Technology — China

Immunology and Microbiology · Life Sciences

17h-index1.1kcitations80works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Galectins and Cancer Biology(18), Lung Cancer Diagnosis and Treatment(16), Macrophage Migration Inhibitory Factor(15), Glycosylation and Glycoproteins Research(12), Advanced Radiotherapy Techniques(7)

Publications80 total

Letter to the Editor. ASDO for posterior longitudinal ligament in the thoracic spine
Journal of Neurosurgery Spine·2026
Surgical Strategies of Staged Spinal Traction–Fusion for Severe Scoliosis in Osteogenesis Imperfecta Type IV: A Case Report and Literature Review
The International Journal of Spine Surgery·2025Open Access
Morphology-Engineered Cu-Doped CeO<sub>2</sub> with Synergistic Defects for Enhanced Dielectric Polarization and Multifunctional Applications
Langmuir·2025· 1 cited
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)
International Journal of Radiation Oncology*Biology*Physics·2025
PL03.07 Hypofractionated vs Conventional Fractionated Radiotherapy With Concurrent Chemotherapy for LS-SCLC: A Multi-Center Phase III Trial
Journal of Thoracic Oncology·2025
A Review of Advances in Lung Function Imaging and Its Applications for Functional Lung Avoidance in Radiation Therapy
Seminars in Nuclear Medicine·2025· 1 cited
Multiple Tumor-related autoantibodies test enhances CT-based deep learning performance in diagnosing lung cancer with diameters &lt; 70 mm: a prospective study in China
BMC Pulmonary Medicine·2025Open Access
Low-dose lipopolysaccharide modulates the RNF4-induced SUMO-dependent degradation of Nrf2 to mitigate oxidative stress in spinal cord injury
Naunyn-Schmiedeberg s Archives of Pharmacology·2025
R-ALPS: A randomized, double-blind, placebo-controlled, multicenter phase III clinical trial of TQB2450 with or without anlotinib as maintenance treatment in patients with locally advanced and unresectable (stage III) NSCLC without progression following concurrent or sequential chemoradiotherapy.
Journal of Clinical Oncology·2025
Low-Dose Lipopolysaccharide Alleviates Neuronal Apoptosis and Oxidative Stress in Rats with Spinal Cord Injury by Inducing Nrf2 m6A Methylation Modification via Suppressing ALKBH5
Neurochemical Research·2025· 1 citedOpen Access
3427 Temporal analysis of 4DCT subregional respiratory dynamics based on machine learning for lung function assessment
Radiotherapy and Oncology·2025
Construction and validation of a risk stratification model based on Lung-RADS® v2022 and CT features for predicting the invasive pure ground-glass pulmonary nodules in China
Insights into Imaging·2025· 1 citedOpen Access
Consensus statement on the exploration of clinical translation and application of electron ultra‐high dose rate FLASH radiotherapy
Precision Radiation Oncology·2025· 10 citedOpen Access
Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
Frontiers in Oncology·2024Open Access
Figure S1+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024Open Access
Figure S3+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024Open Access
Figure S6+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024Open Access
Figure S5+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024Open Access
Figure S4+legend from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024Open Access
Table S1, S2, S3 from Targeting Galectin-1 Overcomes Paclitaxel Resistance in Esophageal Squamous Cell Carcinoma
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Bing Li(9), Jing Cai(8), Allen L. Richards(7), Ge Ren(6), Xiaoli Zheng(4), Yufei Lu(4), Alice N. Maina(3), Hui Luo(3), Yunhan Wang(3), Qinfu Dan(3), Kimberly A. Bishop‐Lilly(3), Yanan Sun(3), Weitao Yao(3), Xinzhi Teng(3), Yuhua Huang(3), Ran Zhao(3), Hui Luo(3), Qingcheng Meng(3), Pengrui Gao(3), Zhi Chen(3)